Rational design of peptide-based HIV proteinase inhibitors
- PMID: 2183354
- DOI: 10.1126/science.2183354
Rational design of peptide-based HIV proteinase inhibitors
Abstract
A series of peptide derivatives based on the transition-state mimetic concept has been designed that inhibit the proteinase from the human immunodeficiency virus (HIV). The more active compounds inhibit both HIV-1 and HIV-2 proteinases in the nanomolar range with little effect at 10 micromolar against the structurally related human aspartic proteinases. Proteolytic cleavage of the HIV-1 gag polyprotein (p55) to the viral structural protein p24 was inhibited in chronically infected CEM cells. Antiviral activity was observed in the nanomolar range (with one compound active below 10 nanomolar) in three different cell systems, as assessed by p24 antigen and syncytium formation. Cytotoxicity was not detected at 10 and 5 micromolar in C8166 and JM cells, respectively, indicating a high therapeutic index for this new class of HIV proteinase inhibitors.
Similar articles
-
In vitro inhibition of HIV-1 proteinase by cerulenin.FEBS Lett. 1990 Feb 26;261(2):373-7. doi: 10.1016/0014-5793(90)80595-a. FEBS Lett. 1990. PMID: 1690152
-
Substitution of proline with pipecolic acid at the scissile bond converts a peptide substrate of HIV proteinase into a selective inhibitor.Biochem Biophys Res Commun. 1990 May 31;169(1):310-4. doi: 10.1016/0006-291x(90)91469-9. Biochem Biophys Res Commun. 1990. PMID: 2190554
-
A synthetic HIV-1 protease inhibitor with antiviral activity arrests HIV-like particle maturation.Science. 1990 Jan 26;247(4941):454-6. doi: 10.1126/science.2405486. Science. 1990. PMID: 2405486
-
Specificity of retroviral proteases: an analysis of viral and nonviral protein substrates.Methods Enzymol. 1994;241:279-301. doi: 10.1016/0076-6879(94)41069-0. Methods Enzymol. 1994. PMID: 7854182 Review. No abstract available.
-
Subsite preferences of retroviral proteinases.Methods Enzymol. 1994;241:254-78. doi: 10.1016/0076-6879(94)41068-2. Methods Enzymol. 1994. PMID: 7854181 Review. No abstract available.
Cited by
-
Saquinavir inhibits early events associated with establishment of HIV-1 infection: potential role for protease inhibitors in prevention.Antimicrob Agents Chemother. 2012 Aug;56(8):4381-90. doi: 10.1128/AAC.00399-12. Epub 2012 Jun 4. Antimicrob Agents Chemother. 2012. PMID: 22664974 Free PMC article.
-
An engineered retroviral proteinase from myeloblastosis associated virus acquires pH dependence and substrate specificity of the HIV-1 proteinase.EMBO J. 1992 Mar;11(3):1141-4. doi: 10.1002/j.1460-2075.1992.tb05154.x. EMBO J. 1992. PMID: 1547777 Free PMC article.
-
Copper inhibits the protease from human immunodeficiency virus 1 by both cysteine-dependent and cysteine-independent mechanisms.Proc Natl Acad Sci U S A. 1991 Jul 1;88(13):5552-6. doi: 10.1073/pnas.88.13.5552. Proc Natl Acad Sci U S A. 1991. PMID: 2062837 Free PMC article.
-
Potent and selective inhibition of human immunodeficiency virus (HIV)-1 and HIV-2 replication by a class of bicyclams interacting with a viral uncoating event.Proc Natl Acad Sci U S A. 1992 Jun 15;89(12):5286-90. doi: 10.1073/pnas.89.12.5286. Proc Natl Acad Sci U S A. 1992. PMID: 1608936 Free PMC article.
-
Cryo-EM for Small Molecules Discovery, Design, Understanding, and Application.Cell Chem Biol. 2018 Nov 15;25(11):1318-1325. doi: 10.1016/j.chembiol.2018.07.006. Epub 2018 Aug 9. Cell Chem Biol. 2018. PMID: 30100349 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
